H. Yokomise

Bevacizumab‐induced hand‐foot syndrome: circumscribed type

K. Yoneda, S. Ishikawa, K. Nakai, 2010, The British journal of dermatology.

Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.

M. Fukushima, H. Wada, S. Hitomi, 2000, International journal of oncology.

Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.

R. Haba, H. Wada, K. Kadota, 2011, International journal of oncology.